The RESTART Trial Explores Drug Targeting Toxic HIV Protein
What if the secret to why some people living with HIV fail to fully recover their health, despite effective antiretroviral ...
Tag: antiretroviral therapy limitations
HIV Reprograms CD4+ T Cells for Latency
In a landmark study published in Nature Microbiology, researchers have unveiled a revolutionary insight into the enigmatic interplay between HIV ...
NIH Launches Initiative to Develop Childhood HIV Vaccine
A groundbreaking initiative spearheaded by investigators at Weill Cornell Medicine has secured a five-year grant totaling $20.8 million from the ...
NIH Grant Supports Innovative Research Targeting the Root Causes of HIV Persistence
A revolutionary multi-institutional initiative spearheaded by researchers at Weill Cornell Medicine has secured an ambitious five-year, $14.9 million grant from ...
Modeling HIV Cure’s Impact on Transmission Dynamics
In a groundbreaking advancement towards combating the global HIV epidemic, recent research led by De Bellis, A. and colleagues offers ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!